According to Xilong Science's announcement, Jingge Private Equity, a shareholder holding more than 5% of the shares, reduced its holdings by 5.7392 million shares through centralized bidding on January 7, 2026, accounting for 0.980697% of the total share capital. After the holdings were reduced, its holdings fell from 35 million shares to 29.268 million shares, and the ratio dropped from 5.980693% to 4.999996%. It is no longer a shareholder holding 5% or more of the shares. This holdings reduction is consistent with the pre-disclosure plan. The holdings reduction plan has not yet been completed, and will not result in changes in the company's controlling shareholders or actual controllers.

According to Xilong Science's announcement, Jingge Private Equity, a shareholder holding more than 5% of the shares, reduced its holdings by 5.7392 million shares through centralized bidding on January 7, 2026, accounting for 0.980697% of the total share capital. After the holdings were reduced, its holdings fell from 35 million shares to 29.268 million shares, and the ratio dropped from 5.980693% to 4.999996%. It is no longer a shareholder holding 5% or more of the shares. This holdings reduction is consistent with the pre-disclosure plan. The holdings reduction plan has not yet been completed, and will not result in changes in the company's controlling shareholders or actual controllers.